543271 Stock Overview
Engages in the life science products and solutions in India, the United States, Europe, China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 543271 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Jubilant Ingrevia Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹765.15 |
| 52 Week High | ₹884.95 |
| 52 Week Low | ₹421.60 |
| Beta | 0.42 |
| 1 Month Change | 12.43% |
| 3 Month Change | 1.47% |
| 1 Year Change | 53.01% |
| 3 Year Change | 45.40% |
| 5 Year Change | n/a |
| Change since IPO | 182.08% |
Recent News & Updates
Recent updates
Shareholder Returns
| 543271 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -9.5% | -3.8% | -4.3% |
| 1Y | 53.0% | 5.4% | 19.1% |
Return vs Industry: 543271 exceeded the Indian Chemicals industry which returned 5.4% over the past year.
Return vs Market: 543271 exceeded the Indian Market which returned 19.1% over the past year.
Price Volatility
| 543271 volatility | |
|---|---|
| 543271 Average Weekly Movement | 6.6% |
| Chemicals Industry Average Movement | 5.8% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: 543271 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 543271's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 2,283 | Deepak Jain | jubilantingrevia.com |
Jubilant Ingrevia Limited engages in the life science products and solutions in India, the United States, Europe, China and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions.
Jubilant Ingrevia Limited Fundamentals Summary
| 543271 fundamental statistics | |
|---|---|
| Market cap | ₹120.86b |
| Earnings (TTM) | ₹1.76b |
| Revenue (TTM) | ₹41.10b |
68.8x
P/E Ratio2.9x
P/S RatioIs 543271 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 543271 income statement (TTM) | |
|---|---|
| Revenue | ₹41.10b |
| Cost of Revenue | ₹20.89b |
| Gross Profit | ₹20.21b |
| Other Expenses | ₹18.46b |
| Earnings | ₹1.76b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 28, 2025
| Earnings per share (EPS) | 11.11 |
| Gross Margin | 49.18% |
| Net Profit Margin | 4.27% |
| Debt/Equity Ratio | 25.3% |
How did 543271 perform over the long term?
See historical performance and comparisonDividends
0.7%
Current Dividend Yield43%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 07:47 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jubilant Ingrevia Limited is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Satish Kumar | CGS International |
| Siddharth Gadekar | Equirus Securities Private Limited |
| Prateek Parekh | Nuvama Wealth Management Limited |